GSK-LSD1 dihydrochloride

CAS: 2102933-95-7

Ref. 3D-CJD93395

Produktinformation

• Name: GSK-LSD1 dihydrochloride
• CAS: 2102933-95-7

Beschreibung

GSK-LSD1 is a potential drug for the treatment of cervical cancer and myeloid leukemia. GSK-LSD1 has been shown to induce autophagy, which is a process by which cells break down and recycle their own cellular components. This process also plays a key role in the development of bowel disease, as well as inflammatory bowel disease and leukemias. GSK-LSD1 was shown to inhibit the growth of human myeloid leukemia cells (THP-1) in vitro and reduced the number of leukemic mice with leukemia. The mechanism by which GSK-LSD1 inhibits tumor cell proliferation is unclear, but may be related to its ability to inhibit cell factor or stem cell factor expression.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 289.24 g/mol
• Formel: C₁₄H₂₂Cl₂N₂
• Reinheit: Min. 95%